Imprivata Inc (IMPR) develops and provides digital identity and access management solutions for mission-critical industries including healthcare, financial services and government organizations; its core offerings encompass passwordless single sign-on and multi-factor authentication via Imprivata OneSign; secure communications through Imprivata Cortext; enterprise access management including shared device access, mobile device management, privileged access security and workflow automation; identity governance and administration tools; patient identification technologies; and identity threat detection and response capabilities enhanced by artificial intelligence. Founded in 2002 and headquartered in Waltham, Massachusetts, the company operates in more than 45 countries through offices in the United States, Europe, Australia and other regions, serving over 1,700 customers worldwide with a focus on zero trust security, HIPAA and HITECH compliance, and frictionless access for frontline workers across shared devices, operational technology and clinical workflows. A portfolio company of Thoma Bravo since its 2016 acquisition from public markets, Imprivata recently sold its identity governance and administration business to SailPoint Technologies Inc in December 2024 while entering a strategic go-to-market partnership designating each other as exclusive partners in healthcare access and identity security with planned integrations between Imprivata Enterprise Access Management and SailPoint Identity Security Cloud; in October 2025, it acquired Verosint to integrate AI-powered risk signaling, continuous anomaly detection and automated responses into its platform, advancing passwordless authentication innovations such as FIDO passkeys, face authentication and operational analytics for cloud, SaaS and legacy systems.